Concepedia

Chandra K. Westergaard

CK

Statistics

Publications

4

Citations

377

H-Index

4

Active since

1997

Affiliations

National Cancer Institute(Current)

Frederick National Laboratory for Cancer Research

Chandra K. Westergaard is an author at National Cancer Institute specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

1997–1999

4

Publications

4

Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.

Jian Jian Li, Chandra K. Westergaard, Paritosh Ghosh et al. · PubMed · 1997 · 198 citations

, , +15

Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges

William R. Gamble, Neil A. Durso, Richard W. Fuller et al. · Bioorganic & Medicinal Chemistry · 1999 · 96 citations

, , +3

Vismiaphenones D−G, New Prenylated Benzophenones from <i>Vismia cayennensis</i><sup>†</sup>

Richard W. Fuller, Chandra K. Westergaard, J. W. Collins et al. · Journal of Natural Products · 1998 · 56 citations

, , +9

Alertenone, a Dimer of Suberosenone from <i>Alertigorgia </i>sp.

Heidi R. Bokesch, John W. Blunt, Chandra K. Westergaard et al. · Journal of Natural Products · 1999 · 27 citations

, , +14

1–4 of 4